Spots Global Cancer Trial Database for neoplasms, head and neck
Every month we try and update this database with for neoplasms, head and neck cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Normalcy of Food Intake in Head and Neck Cancer Patients | NCT01110980 | Neoplasms, Head... | Swallow therapy... Individual diet... | 18 Years - | Radboud University Medical Center | |
| A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma | NCT06256588 | Neoplasms, Head... | Dostarlimab Placebo | 18 Years - | GlaxoSmithKline | |
| Immunotherapy With MK-3475 in Surgically Resectable Head and Neck Squamous Cell Carcinoma | NCT02296684 | Cancer of Head ... Head and Neck C... Neoplasms, Head... Carcinoma, Squa... Squamous Cell C... Squamous Cell C... | MK-3475 (neoadj... Surgery Intensity modul... Image-guided ra... Cisplatin MK-3475 (adjuva... Peripheral bloo... | 18 Years - | Washington University School of Medicine | |
| Phase I Chemoprevention Trial With Green Tea Polyphenon E & Erlotinib in Patients With Premalignant Lesions of the Head & Neck | NCT01116336 | Cancer of Head ... Neoplasms, Head... | Erlotinib Green Tea Polyp... | 18 Years - | Emory University | |
| IRESSA in Combination With Cisplatin & Radiotherapy in Patients With Advanced Head & Neck Carcinoma | NCT00242749 | Cancer of Head ... | Gefitinib, Cisp... | 18 Years - 70 Years | AstraZeneca | |
| Efficacy and Safety Study of Oxaliplatin/5-FU in Patients With Recurrent or Metastatic Head and Neck Cancer | NCT01370876 | Cancer of the H... Neoplasms, Head... | Oxaliplatin | 20 Years - 75 Years | Nang Kuang Pharmaceutical Co., Ltd. | |
| Phase 2 Platform Study of Novel Immunotherapy Combinations as First-Line Treatment in Participants With PD-L1 Positive Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck | NCT06062420 | Neoplasms, Head... | Dostarlimab Belrestotug GSK6097608 | 18 Years - | GlaxoSmithKline | |
| Safety Study of SEA-CD40 in Cancer Patients | NCT02376699 | Carcinoma, Non-... Carcinoma, Squa... Hodgkin Disease Lymphoma Lymphoma, B-Cel... Lymphoma, Folli... Lymphoma, Large... Melanoma Neoplasm Metast... Neoplasms, Head... Neoplasms, Squa... Non-Small Cell ... Non-Small Cell ... Non-small Cell ... Squamous Cell C... Squamous Cell C... Squamous Cell C... Squamous Cell N... Lymphoma, Non-H... Pancreatic Aden... | Intravenous (IV... Pembrolizumab Subcutaneous (S... Gemcitabine Nab-paclitaxel | 18 Years - | Seagen Inc. | |
| Study of PDS0101 and Pembrolizumab Combination I/O in Subjects With HPV16 + Recurrent and/or Metastatic HNSCC | NCT04260126 | Metastatic Head... Recurrent Head ... HPV Positive Or... Neoplasms, Head... | Pembrolizumab (... | 18 Years - | PDS Biotechnology Corp. | |
| Safety Study of SEA-CD40 in Cancer Patients | NCT02376699 | Carcinoma, Non-... Carcinoma, Squa... Hodgkin Disease Lymphoma Lymphoma, B-Cel... Lymphoma, Folli... Lymphoma, Large... Melanoma Neoplasm Metast... Neoplasms, Head... Neoplasms, Squa... Non-Small Cell ... Non-Small Cell ... Non-small Cell ... Squamous Cell C... Squamous Cell C... Squamous Cell C... Squamous Cell N... Lymphoma, Non-H... Pancreatic Aden... | Intravenous (IV... Pembrolizumab Subcutaneous (S... Gemcitabine Nab-paclitaxel | 18 Years - | Seagen Inc. | |
| Normalcy of Food Intake in Head and Neck Cancer Patients | NCT01110980 | Neoplasms, Head... | Swallow therapy... Individual diet... | 18 Years - | Radboud University Medical Center | |
| IRESSA in Combination With Cisplatin & Radiotherapy in Patients With Advanced Head & Neck Carcinoma | NCT00242749 | Cancer of Head ... | Gefitinib, Cisp... | 18 Years - 70 Years | AstraZeneca | |
| Phase I Chemoprevention Trial With Green Tea Polyphenon E & Erlotinib in Patients With Premalignant Lesions of the Head & Neck | NCT01116336 | Cancer of Head ... Neoplasms, Head... | Erlotinib Green Tea Polyp... | 18 Years - | Emory University | |
| Nab-Paclitaxel and Cisplatin or Nab-paclitaxel as Induction Therapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck (HNSCC) | NCT02573493 | Squamous Cell C... Carcinoma, Squa... Cancer of Head ... Cancer of the H... Head and Neck C... Neoplasms, Head... | nab-Paclitaxel Cisplatin Cetuximab Intensity-Modul... | 18 Years - | Washington University School of Medicine | |
| Normalcy of Food Intake in Head and Neck Cancer Patients | NCT01110980 | Neoplasms, Head... | Swallow therapy... Individual diet... | 18 Years - | Radboud University Medical Center | |
| Phase 2 Platform Study of Novel Immunotherapy Combinations as First-Line Treatment in Participants With PD-L1 Positive Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck | NCT06062420 | Neoplasms, Head... | Dostarlimab Belrestotug GSK6097608 | 18 Years - | GlaxoSmithKline | |
| Change in Symptom Clusters in HNC Patients | NCT03356093 | Neoplasms, Head... | complete questi... | - | Taipei Medical University | |
| Manual Therapy and Use of the Dynasplint for Trismus in Patients With Head and Neck Cancer | NCT03178110 | Neoplasms, Head... Trismus | Physical therap... | 18 Years - | University of Alberta |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
